Anixa Biosciences granted additional U.S. patent for ovarian cancer vaccine tech

Anixa Biosciences announced that the U.S. Patent and Trademark Office has issued U.S. Patent Number 11,786,489, which broadens protection of Anixa’s novel ovarian cancer vaccine technology. The patent, titled “Ovarian Cancer Vaccines”, was invented by the late Dr. Vincent Tuohy of Cleveland Clinic and covers nucleic acid-based delivery of the vaccine. Anixa exclusively licensed the technology from Cleveland Clinic and is developing the technology in partnership with the not-for-profit, multispecialty academic medical center.